Nataliya Razumilava, MD

Dr. Nataliya Razumilava speaks English and Russian.Dr. Razumilava is a physician-scientist with a clinical and research expertise in biliary disorders (cholangiopathies) and liver cancer. She serves as the Associate Director of the Liver Tumor Program at the University of Michigan. After completion of her fellowships at the Mayo Clinic, Rochester, MN, Dr. Razumilava joined the University of Michigan in 2015 to develop a translational program focused on processes underlying inflammation-driven bile duct damage leading to bile duct regeneration as opposed to progression to fibrosis and cancer. Her research is funded by external (NIDDK, AASLD, AHA, Gilead) and internal awards. In additional to clinical care and research, she is actively involved in professional societies academic activities including education.

University of Michigan Health participates with most health insurance plans.

Liver cancer biology. Cholangiocarcinoma biology. Malignant transformation of the biliary epithelium.